The Safety and Immunogenicity of GTU(®)MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART

Previous studies have shown targeting different tissues via the transcutaneous (TC) and intramuscular injection (IM) with or without electroporation (EP) has the potential to trigger immune responses to DNA vaccination. The CUTHIVTHER 001 Phase I/II randomized controlled clinical trial was designed...

Descripción completa

Detalles Bibliográficos
Autores principales: Haidari, G., Day, Suzanne, Wood, M., Ridgers, H., Cope, Alethea V., Fleck, Sue, Yan, Celine, Reijonen, Kalevi, Hannaman, Drew, Spentzou, Aggeliki, Hayes, Peter, Vogt, A., Combadiere, Behazine, Cook, Adrian, McCormack, Sheena, Shattock, Robin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923267/
https://www.ncbi.nlm.nih.gov/pubmed/31921170
http://dx.doi.org/10.3389/fimmu.2019.02911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923267/
https://www.ncbi.nlm.nih.gov/pubmed/31921170
http://dx.doi.org/10.3389/fimmu.2019.02911

Ejemplares similares